FindTrial
Sign In

The early diagnostic value of long noncoding RNA in serum and tissue on detecting pancreatic cancer

The early diagnostic value of long noncoding RNA in serum and tissue on detecting pancreatic cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DCD-15007021
Enrollment
Unknown
Registered
2015-09-07
Start date
2015-09-07
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer

Interventions

Gold Standard:
Index test:

Sponsors

The First Affiliated Hospital of Harbin Medicial University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients whose medicial history, imaging and auxiliary examination were suspected of pancreatic cancer, and the intraoperative and postoperative pathological diagnosis confirmed pancreatic cancer.

Exclusion criteria

Exclusion criteria: Patients who were confirmed of other malignant tumors or hematological diseases.

Design outcomes

Primary

MeasureTime frame
long noncoding RNA;—

Countries

China

Contacts

Public ContactBEI SUN
sunbei70@tom.com+86 0451 85555734

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026